MedTrace Logo

A Clinical Trial of IntensiVE Dialysis

NCT00649298 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-12-03

No results posted yet for this study

Summary

This study will assess clinical outcomes of extended weekly hours of haemodialysis (\>= 24 hours per week) compared with standard hours of haemodialysis (\<=18 hours/week) in people with ESKD.

Conditions

Interventions

PROCEDURE

haemodialysis

Comparison of different weekly duration of haemodialysis treatment

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • The George Institute

    lead OTHER

Principal Investigators

  • Vlado Perkovic, MBBS PhD · The George Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2014-07-31
Completion
2014-10-31

Countries

  • Australia
  • Canada
  • China
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00649298 on ClinicalTrials.gov